Su Zhen
Director/Board Member at KARYOPHARM THERAPEUTICS INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sean McCarthy | M | 57 | 14 years | |
| Richard Paulson | M | 56 | 4 years | |
| Helene von Roeder | F | 54 | 5 years | |
| Lloyd Rowland | M | 67 | 6 years | |
| Chris Ogden | M | 40 | 3 years | |
| Michael Kleinemeier | M | 67 | 5 years | |
| Renate Koehler | M | - | 5 years | |
| Alan Ashworth | M | 63 | 3 years | |
| Michael Mano | M | 47 | 4 years | |
| John Hastewell | M | - |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | 6 years |
| Sascha Held | M | - | 5 years | |
| Garen Bohlin | M | 76 | 11 years | |
| Anne Lange | F | - | 5 years | |
| Matthew Young | M | 54 | 9 years | |
| Daniel Thelen | M | - | 5 years | |
| Simon Thelen | M | 44 | 5 years | |
| Danny Bar-Zohar | M | - | 4 years | |
| Marcia Belvin | M | 57 | 6 years | |
| Sohanya Cheng | F | 41 | 3 years | |
| Accumanno James | M | - | 3 years | |
| Peter Emanuel Merck | M | - | 5 years | |
| Rupert Vessey | M | 59 |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | 6 years |
| Christy Oliger | F | 54 | 4 years | |
| Belén Garijo López | M | 62 | 4 years | |
| Mike Mason | M | 49 | 5 years | |
| Mani Mohindru | M | 52 | 4 years | |
| Chen Schor | M | 51 | 4 years | |
| Elaine Jones | M | 69 | 5 years | |
| Deepa Pakianathan | M | 59 | 11 years | |
| Mansoor Mirza | M | 63 | 14 years | |
| James Meyers | M | 59 | 6 years | |
| Barry Greene | M | 60 | 11 years | |
| Halley Gilbert | F | 54 | 4 years | |
| Chris Round | M | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 7 years |
| Seth Harrison | M | 63 |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | - |
| Laura Matz | F | - | 5 years | |
| Andrew Bayliffe | M | - |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | 3 years |
| Reshma Rangwala | M | 46 | 2 years | |
| Stuart Poulton | M | 51 | 2 years | |
| Lisa DiPaolo | F | - | 2 years | |
| Joseph Yanchik | M | 60 |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | - |
| Yu Waye Chu | M | 56 | 1 years | |
| Brian Austad | M | - | 11 years | |
| Jeffrey Landau | M | 46 | 3 years | |
| Ravi Kiron | M | 64 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 7 years |
| Aaron Kantoff | M | 29 |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | - |
| Matthias J. Heinzel | M | 57 | 5 years | |
| Danielle Olander | F | - | 10 years | |
| Hong He | M | 55 | 4 years | |
| Peter Guenter | M | 61 | 3 years | |
| Hong Chow | M | 53 | 3 years | |
| Anna Batarina | F | - |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | - |
| Elhan Webb | F | - | 2 years | |
| Arlene Sharpe | M | - |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | - |
| Ken Smith | M | - |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | - |
| Mark J Smyth | M | - |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | - |
| E. John Wherry | M | - |
Marengo Therapeutics, Inc.
Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | - |
| Gunnar Romer | M | - | 5 years | |
| Amama Sadiq | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Cameron Peters | M | 64 | - | |
| Maria Rivas | M | 60 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 6 years |
| Gary Zieziula | M | 69 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 4 years |
| Markus Bamberger | M | 58 | 5 years | |
| Veit Ulshöfer | M | 61 | 23 years | |
| Peter Honig | M | 67 | 2 years | |
| Yao Lee | M | 54 | 2 years | |
| Joseph Leveque | M | 63 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 2 years |
| Mark DeLong | M | 47 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 11 years |
| Thomas Möller | M | - | 2 years | |
| Maya Martinez-Davis | F | 54 | 3 years | |
| Rehan Verjee | M | 43 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 3 years |
| Laszlo Radvanyi | M | 63 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 3 years |
| Inderpal Singh | M | 58 | 2 years | |
| Tatyana Staneva | F | - | 8 years | |
| Scott Filosi | M | - | - | |
| Piotr Wierzchowiec | M | - | - | |
| Natalia Novac | F | - | 4 years | |
| Alise Reicin | M | 63 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 3 years |
| Udit Batra | M | 53 | 9 years | |
| Tobias Thelen | M | 48 | 5 years | |
| Mechthild Auge | M | 66 | 18 years | |
| Simon Sturge | M | 65 | 6 years | |
| Anand Nambiar | M | 49 | 2 years | |
| John Huycke | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 9 years |
| Elizabeth Jobes | F | 57 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 1 years |
| Constantin Birnstiel | M | - | - | |
| Crocifissa Attardo | F | 62 | 23 years | |
| Michaela Freifrau von Glenck | F | 77 | 11 years | |
| Siegfried Karjetta | M | 70 | 5 years | |
| Albrecht Merck | M | 74 | 14 years | |
| Gregor Schulz | M | 74 | 5 years | |
| Heidi Fagerholm | M | 60 | - | |
| Uta Kemmerich-Keil | F | 58 | 19 years | |
| Craig Millian | M | 56 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 6 years |
| Theo Siegert | M | 77 | 13 years | |
| Keyarasch Parssanedjad | M | - | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 56 | 58.33% |
| Germany | 41 | 42.71% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Su Zhen
- Personal Network
